News

Complement Therapeutics Secures €72 Million in Series A Financing...

Continue Reading

Alex Therapeutics extends financing round to €4.75M with leading life science VC — Hadean Ventures…

Continue Reading

Alex Therapeutics and Vicore Pharma today announce the first study subject enrolled in the pivotal…

Continue Reading

Step Pharma Announces First Patient Dosed with STP938, the World’s Most Advanced CTPS1 Inhibitor, in…

Continue Reading

Gesynta Pharma prepares Phase II study of GS-248 in endometriosis following ground-breaking data from a…

Continue Reading

Alex Therapeutics presents results from digital therapeutic pilot study showing nearly 50% reduction in anxiety…

Continue Reading

Cardior Announces First Patient Dosed in Phase 2 Study — Hadean Ventures Home Portfolio Team…

Continue Reading

Gesynta Pharma completes patient enrollment in its Phase II study in systemic sclerosis — Hadean…

Continue Reading

Attgeno AB announces fully subscribed share issue to complete clinical phase II study in acute…

Continue Reading

Attgeno announces approval of initiation of Phase 2 clinical trial of Supernitro...

Continue Reading